November 4, 2026 · Journal of minimally invasive gynecology · DOI: 10.1016/j.jmig.2026.10.022

Management of Retained Products of Conception (RPOC) with Hysteroscopic Morcellator: A Systematic Review and Meta-analysis of Efficacy, Safety, and Procedural Outcomes.

Listen to this summary

This systematic review and meta-analysis asks whether hysteroscopic morcellation (HM) is effective and safe for treating retained products of conception (RPOC). Pooling four studies (two RCTs, one prospective, one retrospective), the authors found a complete removal rate of 95.0%, with low pooled rates of complications (7.5% intraoperative, 3.4% postoperative) and de novo intrauterine adhesions (5.2%). They conclude that HM appears highly effective and low-risk, but current evidence is too limited to show it is superior to conventional surgical approaches, so adequately powered comparative trials are needed.

Gianluca Raffaello Damiani, Daniela Turoli, Giuseppe Muzzupapa, Tommaso Di Fonzo, Luca Maria Schounauer, Andrea Tinelli, Marco Ferrante, Giuseppe Trojano, Marco Cerbone, Antonio Malvasi, Amerigo Vitagliano

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play